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2.3
General observation on feed intake, heart rate and haematology 172 There was a general decrease in feed consumption in the two groups after 24 hours 173 intravenous administration of both free-DOX and CSNP-DOX. However, the heart 174 rates during the period were within the normal range in both groups with no 175 statistically significant changes were observed in the haematological profile within 176 48 hours with p > 0.05 in all of the parameters as shown in Table 3 . All of the dogs 177 were clinically healthy with no clinical evidence of systemic disturbance observed. indicates that the method was selective for the detection of DOX with a clear 183 resolution between DOX peak and that of the internal standard as shown in figure 5 . 184 The excellent extraction yield from the plasma was evident by the low interference The average recovery extraction was determined in triplicate of the blank plasma was 195 89.87% recovery from 1 µg/mL of DOX (Table 4 ). The limit of detection (LOD) of 196 DOX at the ratio of 4:1 in the organic solvent was 549.90 ng/mL which corresponds 197 to signal to noise of the method developed with a lower limit of quantification (LOQ) 198 at 1666.0 ng/mL as shown in Table 5 . 199 2.5 Doxorubicin plasma to whole blood partition fraction 200 Free-DOX has a significant higher fraction of DOX in plasma and red blood cells 201 against the free-DOX being 5.6% as shown in Table 7 below.
231
The retention time for DOX was 4.42 minutes with the highest plasma peak 232 concentration at 26.75 ± 0.06 µg/mL and lowest plasma peak concentration at 2.22 ± 233 0.15 µg/mL as the lowest detectable concentration which is equivalent to the 13.6% 
Discussion
236
In this study, we hypothesized that CSNP is pH-stimuli responsive drug carrier that employed. This further confirmed that the dialysis bag diffusion method is a more accurate method for drug release kinetic assay as earlier suggested by [31] . In 263 addition, our findings were consistent with [8] , [41] who found that the release 264 profile of encapsulated drugs on nanocarriers depends on the environment of the 265 receiving medium in which the nanocarrier is suspended.
266
As expected, the CSNP retained DOX at the neutral pH and rapidly released the drug 267 upon triggering by weak acidic pH in a similar release pattern as reported by [33] . The accuracy of the method developed was within the acceptable range of the For the preparation of CSNP-DOX, a co-precipitation method was employed to 426 incorporate DOX to the synthesized nanocarrier [28] . Characterization of the 427 synthesized nanocarrier and conjugated carrier for particle size, morphology and whole blood separately and were incubated at 37 °C for 1 hour. The samples were 503 centrifuged at 5000 x g for 15 minutes at 18 °C to separate the plasma from the cells.
504
DOX was extracted from the plasma and analyzed by the established bio-analytical 505 method. 
